chrisvoncsefalvay/vaers-outcomes huggingface dataset:
His shoulder is really sore/shoulder is really hurting; soreness to his arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61-year-old male patient received bnt162b2 (BNT162B2), administration date 27May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "His shoulder is really sore/shoulder is really hurting"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "soreness to his arm".  Additional information: The patient just took the COVID vaccine yesterday at the hospital. He was wondering how long his arm would be sore. The patient wanted to know if shoulder was the normal location for giving the shot. His shoulder was really sore. It was really hurting. The patient wanted to know how long was his shoulder going to hurt. The patient was also experiencing soreness to his arm.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fever up to 101 F; itching; severe head and spine pain; severe head and spine pain; Extreme fatigue; Erythematous; Loss of voice; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6201), via an unspecified route of administration in left arm on 12Feb2021 12:30 as single dose for covid-19 immunisation. Medical history included psoriatic arthropathy, basedow's disease, psoriasis. Concomitant medications included levothyroxine sodium (SYNTHROID) (MANUFACTURER UNKNOWN); estrogens conjugated, medroxyprogesterone acetate (PREMPRO) (MANUFACTURER UNKNOWN). The patient previously took fentanyl and experienced drug hypersensitivity and bnt162b2 (product=COVID 19, brand=Pfizer BioNTech, lot number=EL9262, administration date=21Jan2021, administration time=04:00 PM, vaccine location=Left arm, dose number=1).  On 13Feb2021 06:30 and experienced fever up to 101 f, itching, severe head and spine pain, severe head and spine pain, extreme fatigue, erythematous. On an unspecified date in Feb2021, patient experienced loss of voice. 18 hours post injection, severe head and spine pain, extreme fatigue, fever up to 101 F persisting 36 hours. Loss of voice 96 hours later, intermittent fever. Erythematous, hot area, raised (size of an orange) with itching in the area persists. On 13Feb2021, the patient underwent lab tests which included body temperature: up to 101 fahrenheit (intermittent fever). The patient did not receive any treatment for the events. The clinical outcomes of the fever up to 101 f, itching, severe head and spine pain, severe head and spine pain, extreme fatigue, erythematous, loss of voice were recovering. No follow-up attempts are possible.
R arm swollen and hot elbow to shoulder; couldn't lift arm more than 1" without pain; fever/chills; 1/14/2012 - R arm still hot and swollen, but better.
Swelling and rash at injection site. Treated with cool compress, Benadryl and protection from direct sun exposure.
No additional AE; inadvertent administration of PEDVAXHIB after TE; This spontaneous report was received from a reporter (other) and refers to a 17-month-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 01-MAY-2023, the patient was vaccinated with improperly stored (Product storage error) dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot # reported and confirmed as: W002453, expiration date reported and confirmed as: 24-JUN-2024 (exact dose, site and route of administration were not provided) for prophylaxis. Temperature excursion details: 65.2 degree Fahrenheit for 9 hours 45 minutes; 32.4 degree Fahrenheit for 42 hours 45 minutes. No symptoms or additional adverse event reported.
Itchy left palm, swollen knuckles, itchy knuckles, achy pain in left hand.
Consumer reports that daughter was vaxed in 1978 & exp swelling @ the inject site & screaming;
Fever up to 104, chills, fatigue, body aches, severe vertigo, dizziness, nausea
Pt admitted post fall for left hip fracture.  Found to be COVID positive, but denies symptoms.
I am not sure if it is related but the day after receiving the vaccine I felt extremely ill. I was also pregnant at the time of receiving the shot and miscarried one week later.
Tiredness started about 3 hours after the vaccination.   Twelve hours after the vaccination I have extreme achiness of the whole body.    This included chills from time to time along with low energy and extreme tiredness along with loss of appetite.  This lasted for about 36 hours.
Angioedema, CoughWheeze, sweats/chils w/o true fever, lympadenopathy; ipsilateral axilla, neck & groin. Fatigue, weakness Narrative: Dose #2 Thurs, 7 Jan.. 10 min later: Asthma attack & throat swelling took Benadryl tabs fatigue & weakness. Day 2: On Friday Jan 8 Thurs awoke with lymphadenopathy, Axillary f/c groin & neck also Asthma attack & throat swelling took Benadryl tabs fatigue & weakness. Dose 1 no problems
1st day generally aches and pains throughout body  . 2nd day left arm pain, swelling and redness at injection site, pain and swelling under left arm and excessive tiredness and lethargic.   3rd day still experiencing pain and swelling on arm and in armpit, and tiredness.   4th day arm still painful and swollen, armpit less sore but still swollen. Less tired but not feeling normal.
Shot was administered improperly. I was told to put my arm on the table, and then the shot was administered into my arm (deltoid area - although high up) while my arm was elevated on the table. Shoulder pain occurred within 30 minutes and has gotten steadily worse. where I can no longer move my arm. This did not occur for my first shot, which was administered normally at a 90 degree angle.  After getting  a second opinion from a registered nurse practitioner, I was told this was an incorrect way to have this  type of shot administered. I should have had my arm down by my side for the injection, unlike the instructions I received from the person administering my shot.
This spontaneous report was received from a registered nurse via medical assistant and refers to a 12-month-old female patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, past drugs and drug allergies were not reported. On 11-OCT-2017, the patient was vaccinated with improperly stored M-M-R II (lot # M034387; expiry date: 19-JUL-2018) (dosing details were not provided) for prophylaxis. Temperature excursion details of the vaccine were not provided. This is one of the several reports received from the same source. Sender's Comments: US-009507513-1709USA008861: US-009507513-1710USA013424: US-009507513-1710USA013470: US-009507513-1710USA013465: US-009507513-1710USA013440: US-009507513-1710USA013468: US-009507513-1710USA013442: US-009507513-1710USA013445: US-009507513-1710USA013460: US-009507513-1710USA013463: US-009507513-1710USA013464: US-009507513-1710USA013438: US-009507513-1710USA013439: US-009507513-1710USA013450: US-009507513-1710USA013430: US-009507513-1710USA013469: US-009507513-1710USA013467: US-009507513-1710USA013435: US-009507513-1710USA013434: US-009507513-1710USA013432: US-009507513-1710USA013428: US-009507513-1710USA013437: US-009507513-1710USA013441: US-009507513-1710USA013443: US-009507513-1710USA013444: US-009507513-1710USA013446: US-009507513-1710USA013447: US-009507513-1710USA013448: US-009507513-1710USA013436: US-009507513-1710USA013449: US-009507513-1710USA013451: US-009507513-1710USA013452: US-009507513-1710USA013454: US-009507513-1710USA013455: US-009507513-1710USA013456: US-009507513-1710USA013457: US-009507513-1710USA013458: US-009507513-1710USA013459: US-009507513-1710USA013461: US-009507513-1710USA013462: US-009507513-1710USA013466: US-009507513-1710USA013427: US-009507513-1710USA013471: US-009507513-1710USA013472: US-009507513-1710USA013473: US-009507513-1710USA013474: US-009507513-1710USA013475: US-009507513-1710USA013476: US-009507513-1710USA013425: US-009507513-1710USA013433: US-009507513-1710USA013423: US-009507513-1710USA013040: US-009507513-1710USA013426: US-009507513-1710USA013429: US-009507513-1710USA013431: US-009507513-1709USA008666: Original Case: 1709USA008666: US-009507513-1710USA014650: Original Case: 1710USA014649: US-009507513-1710USA014651: Original Case: 1710USA014649: US-009507513-1710USA014649: Original Case: 1710USA014649.
(R) deltoid red patch 10 x 6.5 cm irregular border, indurated, warm to touch one day after the vaccine was administered. Near vaccine site was a patch of red papules grouped together where MMRV was administered. (R) upper arm posterior where MMRV.
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: pulmonary cirrhosis (Patient was not taking Inhaler). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On 2022, the patient experienced suspected covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection on NOV-2022. This report was non-serious.
Blurry vision, distant sound, light-headed, elevated HR (155) while sitting and not doing anything. Resolved within 15 min- felt foggy-headed after.  Similar episode April 2nd. April 22nd same thing- lasted >2 hours with more symptoms (numb upper lip, shaking, pale, near syncopal episode) heart rate between 200-100 for 2 hours straight. Went to UC. Admitted overnight for observation.  Diagnosed with inappropriate sinus tachycardia. Wore a home heart monitor for 2 weeks. ER visit again April 25th- via EMS from home. Same symptoms. Started on metoprolol. 2 more ER visits with the same symptoms on May 11th and May 16th. Went on disability from work. Electro Physiology appt May 26th. Diagnosed with disautonomia.
This spontaneous report was received from a nurse and refers to a 6 month old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 14-SEP-2017, the patient was vaccinated with improperly stored vaccines, RECOMBIVAX HB (dosing details not reported) (lot # N006321, expiry date: 08-NOV-2019) and ROTATEQ (dosing details not reported) (lot # M044397, expiry date: 20-JUN-2018, orally) for prophylaxis. No adverse effects were reported. The administered vaccines underwent a temperature excursion from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011.
Systemic: Dizziness / Lightheadness-Mild, Additional Details: Patient felt overwhelemed due to fobia of needles
Patient stated within the hour had itching on face and body. Patient stated had rash around her mouth. Patient took benadryl and spoke to doctor. Patient stated was just itchy several days later as of 3/31
The night of the vaccine I got a mild headache during the night and it lasted about 24 hours.  A WEEK AFTER THE VACCINE I AM EXPERIENCING VERY ITCHY AREA WHERE THE VACCINE WAS INJECTED. IT IS RED AND HOT BUT THERE IS NO PAIN.  I ALSO EXPERIENCED FATIGUE ON THURSDAY, FEB. 4TH.
A hard knot developed. It is red and warm to the touch. She is also running a low grade fever.
head is swollen on the top of her head; Thirsty; bruise on her right knee\bruise on her ankle is on her left leg; Tired; throbbing headache.; fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (head is swollen on the top of her head), POLYDIPSIA (Thirsty), CONTUSION (bruise on her right knee\bruise on her ankle is on her left leg), FATIGUE (Tired) and HEADACHE (throbbing headache.) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003J21-2A, 040B21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jan-2022, the patient experienced POLYDIPSIA (Thirsty), CONTUSION (bruise on her right knee\bruise on her ankle is on her left leg), FATIGUE (Tired), HEADACHE (throbbing headache.) and PYREXIA (fever). On 04-Jan-2022, the patient experienced SWELLING (head is swollen on the top of her head). At the time of the report, SWELLING (head is swollen on the top of her head), POLYDIPSIA (Thirsty), CONTUSION (bruise on her right knee\bruise on her ankle is on her left leg), FATIGUE (Tired), HEADACHE (throbbing headache.) and PYREXIA (fever) outcome was unknown.            No Concomitant medication was reported.    No treatment medications were reported. The patient experienced fever, tired, thirsty, and the patient had a bruise on her right knee. The bruise on her ankle was on her left leg. The patient had a throbbing headache. The patients head was swollen on the top of her head. That started on 04-Jan-2022.   This case was linked to MOD-2022-440740, MOD-2022-440720 (Patient Link).
5 days post vaccinia vaccination on 04/19/2003 awoke at 04:30 with "severe" mid sternal chest pain which lasted approximately 10 min.  Said had episodes of pain off and on throughout the day also some short of breath with activity and high in pain with deep breathing.  To hospital ER 04/19/2003 approximately 22:00 EKG, Labs, and CKR- all normal states diagnosed with dostochondritis and start anti inflammatory meds.
This spontaneous report was received from a healthcare worker regarding an unspecified 6 patients of unknown age and gender. This report pertains to the patient who on 05-DEC-2013 was vaccinated with a dose of M-M-R II, (lot # J003002, expiry date 14-MAR-2015) (dosage regimen unspecified). The healthcare worker reported that 6 clients were vaccinated with the same lot of improperly stored M-M-R II. The healthcare worker reported details of a supported temperature excursion for M-M-R II that were exposed to temperatures of 47Fahrenheit (F) for 1 hour 48 minutes (min), 48.5F for 1 hour 13 min, and 48.5F 1 hour 13 min (also reported as the vaccine was not stored improperly, the products would not be adversely affected by this specific temperature excursion). No adverse effect reported. No further information was available. This case is linked to 1312USA005771, 1312USA010204, 1312USA010205, 1312USA010206 (Same reporter link). Additional information has been requested.
Total hearing loss in left ear.  Woke up one morning and had no hearing.  Was one week after second dose of COVID vaccine.
This case was reported by a physician via sales rep and described the occurrence of headache in a 52-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, several days after receiving SHINGRIX, the patient experienced headache, fever, chills and myalgia. On an unknown date, the outcome of the headache, fever, chills and myalgia were recovered/resolved. It was unknown if the reporter considered the headache, fever, chills and myalgia to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced headache, fever, chills, myalgia for a couple days after the vaccination and the symptoms resolved within 3 days. The reporter agreed to contact for follow up. This case has been linked with case US2018GSK153154, reported by the same reporter.
There is  weakness like when he  goes to grab something or a feeling of pressure, like it will snap off.; he got  Adacel and his right shoulder still hurts/he got a ADACEL shot in his right arm, it has been sore ever since; Initial information received on 14-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 30 years old male patient who got adacel and his right shoulder still hurts/he got a adacel shot in his right arm, it has been sore ever since (injection site pain) and there is  weakness like when he goes to grab something or a feeling of pressure, like it will snap off (hypokinesia), while he received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On 13-Jul-2020, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [lot number not reported and expiration date unknown] via unknown route in the right arm for prophylactic vaccination.  On an unknown date, (Unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE patient right shoulder still hurts/he got a adacel shot in his right arm, it has been sore ever since (injection site pain) and there is  weakness like when he goes to grab something or a feeling of pressure, like it will snap off (hypokinesia).  Final diagnosis was injection site pain, hypokinesia.  Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The events outcome were reported as Unknown.
28AUG91 c/o nausea, dizziness, was sent home; On 29AUG91 c/o nausea only on campazine, was placed on light duty; Seen by MD;
Information has been received from a consumer concerning herself (a "37 year old" female) with food allergies who received MMR II series as a child. She then received a dose of MMR II in 1997 because it was required for her job. A recent rubella titer showed low levels of immunity. This titer was required because she was pregnant. At the time of reporting (17-MAR-2009) the patient was not recovered. Additional information has been requested.
3 days after receiving the vaccination I developed severe generalized numbenss and tingling in my entire body but especailly arms and hands and weakness in my lower extremitites. THe sympotms are still persistnet. I went to see a neurologist about 4 weeks after receiving my vaccination. I was told by the neurologist that similar sympotms have been reported by other patients. I was prescribed Neurontin which did not work but made me very shaky. BLood work was done whcih was negative. I was also seen by my primary care physician. No medications have been ordered.  Still feel very tired and "foggy" since getting the vaccine. The neurological sympotms are affecting my everyday functioning.
PATIENT RECEIVED SECOND DOSE OF COVID VACCINE ACCIDENTLY; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, and dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject received second dose of covid vaccine accidently. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of patient received second dose of covid vaccine accidently was not reported. This report was non-serious.
Patient given Tdap, MCV4, and HPV. After HPV patient blacked out, lean head down forward. He was able to talk after few second. He was pale and clammy. Vitals WNL recovered.
Unknown, tested positive at her other job and reported to us.  PCR we ran did not come back yet.
3rd dose; had 3 (PAC's) show up during a BP test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Nov2021 09:30 (Lot number: FH8020) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: PROZAC; CRESTOR; TERAZOSIN. Past drug history included: None, reaction(s): "Allergy", notes: other medical history: No. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8735, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 28Apr2021, when the patient was 64 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0150, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 07Apr2021, when the patient was 64 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "3rd dose"; SUPRAVENTRICULAR EXTRASYSTOLES (non-serious) with onset 19Nov2021 04:00, outcome "recovering", described as "had 3 (PAC's) show up during a BP test". The event "had 3 (pac's) show up during a bp test" was evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of supraventricular extra systoles.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Had P.,A.C's show up at Blood donation, which alerted me to this condition. they only showed occasionally until the day after my . They are getting better, sometimes none. Just felt I should report. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. No other vaccine in four weeks.  Follow-up attempts are completed. No further information is expected.